[1]刘锋锋,郑建杰.体外膜肺氧合联合主动脉内球囊反搏在高危患者经皮冠状动脉介入治疗中的应用[J].医学信息,2022,35(03):127-129.[doi:10.3969/j.issn.1006-1959.2022.03.032]
　LIU Feng-feng,ZHENG Jian-ji.Application of Extracorporeal Membrane Oxygenation Combined with Intra-aortic Balloon Counterpulsation in Percutaneous Coronary Intervention in High-risk Patients[J].Medical Information,2022,35(03):127-129.[doi:10.3969/j.issn.1006-1959.2022.03.032]
点击复制

体外膜肺氧合联合主动脉内球囊反搏在高危患者经皮冠状动脉介入治疗中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年03期
页码:
127-129
栏目:
临床研究
出版日期:
2022-02-01

文章信息/Info

Title:
Application of Extracorporeal Membrane Oxygenation Combined with Intra-aortic Balloon Counterpulsation in Percutaneous Coronary Intervention in High-risk Patients
文章编号:
1006-1959（2022）03-0127-03
作者:
刘锋锋1; 郑建杰1; 2
1. 西安交通大学，陕西 西安 710049；2.西安交通大学第一附属医院心外科，陕西 西安 710061
Author(s):
LIU Feng-feng1; ZHENG Jian-ji; 1; 2
1. Xi’an Jiaotong University,Xi’an Shaanxi 710049,China;2.Department of Cardiac Surgery,the First Affiliated Hospital of Xi’an Jiaotong University,Xi’an Shaanxi 710061,China
关键词:
体外膜肺氧合; 主动脉内球囊反搏; 高危患者; 经皮冠状动脉介入
Keywords:
Extracorporeal membrane oxygenation; Intra-aortic balloon counterpulsation; High-risk patients; Percutaneous coronary intervention
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2022.03.032
文献标志码:
A
摘要:
目的 评价体外膜肺氧合（ECMO）联合主动脉内球囊反搏（IABP），在高危患者经皮冠状动脉介入治疗（PCI）中的应用效果。方法 选择2019年1月-2021年5月来我院就诊，行经皮冠状动脉介入（PCI）治疗的高危患者50例为研究对象，按照随机数字表法分为对照组和观察组，每组25例。对照组在IABP辅助下行PCI术，观察组行ECMO联合IABP辅助下行PCI术，比较两组治疗效果及预后生存情况。结果 观察组住院时间、IABP使用时间，以及入院到球囊通过时间均较对照组长（P＜0.05）；观察组院内死亡率低于对照组，脱机成功率和院外生存率高于对照组（P＜0.05）；两组术后左心室射血分数均较治疗前改善（P＜0.05），观察组术后左心室射血分数优于对照组，但差异无统计学意义（P＞0.05）；两组平均手术时间和术后并发症比较，差异无统计学意义（P＞0.05）。结论 高危患者行PCI手术治疗时采取IABP联合ECMO辅助支持的治疗效果更显著，能有效提高患者的生存率，改善其心功能，值得临床借鉴应用。
Abstract:
Objective To evaluate the effect of extracorporeal membrane oxygenation (ECMO) combined with intra-aortic balloon pump (IABP) on percutaneous coronary intervention (PCI) in high risk patients.Methods A total of 50 high-risk patients treated with percutaneous coronary intervention (PCI) in our hospital from January 2019 to May 2021 were selected as the research objects, and they were divided into the control group and the observation group according to the random number table method, with 25 cases in each group. The control group received IABP-assisted PCI, and the observation group received ECMO combined with IABP-assisted PCI. The therapeutic effect and prognosis of the two groups were compared.Results The hospitalization time, IABP use time and the time from admission to balloon passage in the observation group were longer than those in the control group (P<0.05). The in-hospital mortality rate of the observation group was lower than that of the control group, and the offline success rate and out-hospital survival rate of the observation group were higher than those of the control group(P<0.05). The left ventricular ejection fraction in the two groups was improved after treatment(P<0.05). The left ventricular ejection fraction in the observation group was better than that in the control group, but the difference was not statistically significant (P>0.05). There was no significant difference in the average operation time and the probability of postoperative complications between the two groups (P>0.05).Conclusion IABP combined with ECMO adjuvant support is more effective in the treatment of high-risk patients with PCI operation, which can effectively improve the survival rate and cardiac function of patients, and is worthy of clinical reference.

参考文献/References:

[1]刘臣,周鹏,赵汉军,等.主动脉内球囊反搏联合体外膜肺氧合支持下行急诊经皮冠状动脉介入治疗并随访6年1例[J].中国介入心脏病学杂志,2019,27(11):59-61.[2]邵劲松,温伟标,余志辉,等.体外膜肺氧合联合主动脉内球囊反搏成功抢救急性心肌梗死并心搏骤停患者1例[J].中华危重病急救医学,2019,31(10):1289-1291.[3]王跃堂,张晶,王旭,等.体外膜肺氧合和主动脉内球囊反搏治疗心脏外科术后合并心原性休克的短期效果[J].中国心血管杂志,2019,24(3):33-38.[4]徐小妹,主有峰,陈希伟,等.体外膜肺氧合联合主动脉球囊反搏救治急性心肌梗死后心源性休克一例报道[J].国际医药卫生导报,2017,23(24):3829-3831.[5]陈宇,郑建勇,李寒,等.体外膜肺氧合联合主动脉内球囊反搏在高危患者经皮冠状动脉介入治疗中的应用[J].中国介入心脏病学杂志,2019,27(4):211-215.[6]罗明华,关怀敏,解金红,等.体外膜肺氧合联合主动脉球囊反搏支持下经皮冠状动脉介入救治高危冠心病10例总结[J].临床心血管病杂志,2019,35(7):43-47.[7]吴建涛,刘峰,牛兆倬,等.StanfordA型主动脉夹层合并症状性心包积液临床疗效分析[J].华南国防医学杂志,2020,34(4):223-227.[8]曾秋棠,彭昱东.机械循环支持在冠状动脉复杂高危患者介入治疗中的应用[J].临床心血管病杂志,2020,36(5):397-400.[9]侯剑峰,陈凯,唐汉韡,等.体外膜肺氧合与主动脉球囊反搏联合辅助救治心血管外科术后心原性休克:阜外医院单中心十一年经验总结[J].中国循环杂志,2019,34(1):66-71.[10]王小兵,熊富权,林德智,等.ST段抬高心肌梗死患者入院时中性粒细胞计数与经皮冠状动脉介入治疗后血管造影无复流的关系[J].徐州医学院学报,2020,40(4):268-273.[11]许志锋,韩振,吴永前,等.体外膜氧合联合主动脉球囊反搏及持续肾替代治疗在心脏术后心源性休克的应用[J].中国体外循环杂志,2020,18(1):25-29.[12]唐绪荣,聂谦,赵珏,等.体外膜肺氧合联合主动脉内球囊反搏治疗急性心肌梗死合并心源性休克1例[J].中南医学科学杂志,2020,48(3):115-118.[13]李侠,胡有东,张枫林,等.老年冠状动脉粥样硬化性心脏病患者冠状动脉病变影响因素的探讨[J].中华损伤与修复杂志(电子版),2016,11(3):204-211.[14]胡思雄,张钲.体外膜肺氧合联合主动脉内球囊反搏辅助下介入治疗左主干病变1例[J].临床合理用药杂志,2020,13(25):169-170.[15]曹毅,李田昌,陈宇,等.体外膜肺氧合辅助下75岁以上高危冠心病患者经皮冠状动脉介入治疗观察[J].中华老年心脑血管病杂志,2021,23(1):34-37.[16]杨丽娜,肖燕,孙琴.体外膜肺氧合联合急诊经皮冠状动脉介入治疗在急性心肌梗死后心脏停搏中的应用效果[J].实用心脑肺血管病杂志,2017,25(10):88-91.[17]邱承杰,陈玉善,解金红,等.体外膜肺氧合联合主动脉内球囊反搏对急性心肌梗死合并心原性休克患者直接经皮冠状动脉介入治疗临床预后的影响[J].中国心血管杂志,2021,26(3):257-261.[18]张歆杰.主动脉内球囊反搏在危重症心脏病患者的应用及对应用时机的研究[D].济南:山东大学,2017.[19]蒙革,吴伟,冯海合,等.主动脉内球囊反搏辅助时机对高危非体外循环冠状动脉旁路移植术患者cTnⅠ和CK-MB及病死率的影响[J].国际病理科学与临床杂志,2018,38(9):1871-1876.[20]阮宗发,陈妙莲,李建伟,等.ECMO联合主动脉内球囊反搏对心脏术后低心排综合征患者心功能及预后的影响[J].中国处方药,2020,18(4):167-168.

相似文献/References:

[1]马洪俊,王玉平,刘 毅.主动脉内球囊反搏联合介入治疗急性心肌梗死伴心力衰竭的效果[J].医学信息,2022,35(13):136.[doi:10.3969/j.issn.1006-1959.2022.13.032]
　MA Hong-jun,WANG Yu-ping,LIU Yi.Effect of Intra-aortic Balloon Counterpulsation Combined with Interventional Therapy on Acute Myocardial Infarction Complicated with Heart Failure[J].Medical Information,2022,35(03):136.[doi:10.3969/j.issn.1006-1959.2022.13.032]
[2]姜文学,韦 巧,王 驰,等.老年ECMO患者早期急性胃肠损伤发生的影响因素分析[J].医学信息,2023,36(12):91.[doi:10.3969/j.issn.1006-1959.2023.12.017]
　JIANG Wen-xue,WEI Qiao,WANG Chi,et al.Analysis of Influencing Factors of Early Acute Gastrointestinal Injury in Elderly Patients with ECMO[J].Medical Information,2023,36(03):91.[doi:10.3969/j.issn.1006-1959.2023.12.017]
[3]康凤尔,姚 杨,曹晓梅,等.ECMO治疗急性呼吸窘迫综合征预后危险因素的Meta分析[J].医学信息,2023,36(23):22.[doi:10.3969/j.issn.1006-1959.2023.23.006]
　KANG Feng-er,YAO Yang,CAO Xiao-mei,et al.Meta-analysis of Prognostic Risk Factors of ECMO in the Treatment of Acute Respiratory Distress Syndrome[J].Medical Information,2023,36(03):22.[doi:10.3969/j.issn.1006-1959.2023.23.006]

更新日期/Last Update: 1900-01-01